Clinical Trial Update: A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Nipocalimab in combination with Certolizumab Pegol in adults with active rheumatoid arthritis has completed,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)
• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2025-10-16